These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17806064)

  • 41. How relevant are the drug-drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?
    Cattaneo D; Formenti T; Astuti N; Meraviglia P; Ridolfo A; Gervasoni C
    J Antimicrob Chemother; 2018 Aug; 73(8):2271-2273. PubMed ID: 29897531
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypersensitivity Reactions in HIV Infected Individuals after Substitution of Antiretroviral Drug Regimen: Need for Pharmacovigilance in the National Program.
    Ghate MV; Kadam DB; Gurav NP; Rewari BB; Gangakhedkar RR
    J Assoc Physicians India; 2015 Oct; 63(10):94-5. PubMed ID: 27608708
    [No Abstract]   [Full Text] [Related]  

  • 43. Pretreatment antiretroviral exposure from recreational use.
    Grelotti DJ; Closson EF; Mimiaga MJ
    Lancet Infect Dis; 2013 Jan; 13(1):10-2. PubMed ID: 23257221
    [No Abstract]   [Full Text] [Related]  

  • 44. Haiti trial supports starting antiretroviral therapy earlier.
    AIDS Patient Care STDS; 2009 Jul; 23(7):577. PubMed ID: 19621995
    [No Abstract]   [Full Text] [Related]  

  • 45. The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?
    Whitlock GG; Patel A; Edwards SG; Benn PD; Miller RF
    Clin Med (Lond); 2012 Jun; 12(3):300-1. PubMed ID: 22783792
    [No Abstract]   [Full Text] [Related]  

  • 46. Free InterApp ARV: The subsequent version of SIMARV® to analyse the clinical relevance of drug interactions with antiretroviral agents in patients with HIV/AIDS.
    Amariles P; Giraldo N; Madrigal-Cadavid J; Granados J
    Res Social Adm Pharm; 2019 Nov; 15(11):1376. PubMed ID: 31353121
    [No Abstract]   [Full Text] [Related]  

  • 47. Nephrotoxicity of antiretroviral agents: is the list getting longer?
    Fine DM; Gallant JE
    J Infect Dis; 2013 May; 207(9):1349-51. PubMed ID: 23382574
    [No Abstract]   [Full Text] [Related]  

  • 48. Epilepsy: Issues with antiepileptic drug use in HIV-infected patients.
    Brew BJ; Thompson J
    Nat Rev Neurol; 2012 Mar; 8(4):187-8. PubMed ID: 22410581
    [No Abstract]   [Full Text] [Related]  

  • 49. Inadequacy of antiretroviral drugs dosage adjustment in HIV patients receiving dialysis.
    Izzedine H; Launay-Vacher V; Deray G
    Kidney Int; 2003 Dec; 64(6):2324. PubMed ID: 14633161
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinically significant drug interactions of antiretrovirals.
    Murínová I
    Cas Lek Cesk; 2019; 158(7-8):289-294. PubMed ID: 31995995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of an antiretroviral regimen in a patient unable to swallow solid oral dosage forms.
    Patti F; Calcagno A; Simiele M; Bonasso M; Di Perri G; D'Avolio A; Bonora S
    Am J Health Syst Pharm; 2016 Jun; 73(11):750-4. PubMed ID: 27208059
    [No Abstract]   [Full Text] [Related]  

  • 52. The critical need for alternative antiretroviral formulations, and obstacles to their development.
    Swindells S; Flexner C; Fletcher CV; Jacobson JM
    J Infect Dis; 2011 Sep; 204(5):669-74. PubMed ID: 21788451
    [No Abstract]   [Full Text] [Related]  

  • 53. Response to 'Communicating information about drug interactions'.
    Back DJ; Gibbons SE
    Br J Clin Pharmacol; 2008 Apr; 65(4):617-8. PubMed ID: 17995974
    [No Abstract]   [Full Text] [Related]  

  • 54. Re-audit of patients initiating antiretroviral therapy.
    Curtis H; Johnson MA; Brook G;
    HIV Med; 2006 Oct; 7(7):486. PubMed ID: 16925737
    [No Abstract]   [Full Text] [Related]  

  • 55. Antiretroviral drugs and the kidney: further precisions.
    Izzedine H; Launay-Vacher V; Deray G
    Kidney Int; 2005 Jul; 68(1):409. PubMed ID: 15954936
    [No Abstract]   [Full Text] [Related]  

  • 56. Conviction reversed over lack of drug interaction testimony.
    AIDS Policy Law; 2006 Aug; 21(15):7. PubMed ID: 16972335
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pitfalls in polytherapy. 10 important interactions to remember].
    Füessl HS
    MMW Fortschr Med; 2002 Jun; 144(25):4-8. PubMed ID: 12136672
    [No Abstract]   [Full Text] [Related]  

  • 58. Ontario overhauls medical audit regime.
    Kondro W
    CMAJ; 2007 Aug; 177(4):334. PubMed ID: 17698817
    [No Abstract]   [Full Text] [Related]  

  • 59. How to manage brainpower.
    Science; 1969 Sep; 165(3898):1106. PubMed ID: 17779800
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk factors involved in orofacial cleft predisposition - review.
    Kawalec A; Nelke K; Pawlas K; Gerber H
    Open Med (Wars); 2015; 10(1):163-175. PubMed ID: 28352691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.